5-HT1B/D antagonist (SB)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT1B/D antagonist (SB)
Drug Alias Name5-HT1B/D antagonist (SmithKline Beecham)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1d (5-HT1d) receptor antagonistsSerotonin 1b (5-HT1b) receptor antagonists
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 1d (5-HT1d) receptor
Therapy Area/IndicationsObsessive-Compulsive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSmithkline Beecham Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSmithkline Beecham Plc
Active IndicationsN/A
Inactive IndicationsObsessive-Compulsive Disorder

Other Information

ATC CodeN/A
Related LinksN/A